OncoBone Ventures is a UK start-up biotech company seeking to develop novel therapies for cancer patients with currently incurable bone metastases. Working together with its wholly owned Finland-based subsidiary, OncoBone Therapeutics, the Company will see the utilization of its proprietary Biomarker Discovery Engine technology and a novel osteoimmuno-oncology (OIO) concept, first described by its directors, to guide the development of effective and safe immunotherapies for cancer patients with bone metastases.
Bone metastases provide a high unmet clinical need. About 70-80% of advanced breast and prostate cancer patients develop bone metastases and there are no effective treatments currently available. Furthermore, bone metastases often decrease quality of life, are painful and can cause severe bone complications, such as spinal cord compression and fractures.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 10 Queen Street Place, London,ec4r 1ag,united Kingdom
- Industry
- Biotechnology
- Keywords
- Tech Manage Corp..
- HQ
- London
Oncobone Therapeutics Ltd Questions
Oncobone Therapeutics Ltd's website is http://www.oncobonetherapeutics.com
Oncobone Therapeutics Ltd's LinkedIn profile is https://uk.linkedin.com/company/oncobone-therapeutics-ltd
Oncobone Therapeutics Ltd has
3 employees.
View email and phone details for 3
employees at Oncobone Therapeutics Ltd.
Oncobone Therapeutics Ltd's industry is
Biotechnology
Oncobone Therapeutics Ltd's top competitors are
Transgen Biotech Co., Ltd,
Kojair Tech Oy,
Origenis Gmbh,
Ileadbms,
Tech Manage Corp.,
Genobiomics Oy,
Finvector Oy,
Coca-Cola Femsa,
Vidarium,
Oms Technologies.
Oncobone Therapeutics Ltd's categories are Biotechnology
Oncobone Therapeutics Ltd's founding year is 2021
